Arrowstreet Capital
CANO

Arrowstreet Capital’s Cano Health, Inc. CANO Stock Holding History

Arrowstreet Capital’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-309
Closed -$391K – 1813
2021
Q3 		$391K Sell
309
-1,711
-85% -$2.07M ﹤0.01% 1448
2021
Q2 		$2.44M Buy
2,020
+1,648
+443% +$2.22M ﹤0.01% 1291
2021
Q1 		$493K Buy
+372
New +$527K ﹤0.01% 2002

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arrowstreet Capital's CANO Position: Q4 2021 in Review

Arrowstreet Capital sold out of Cano Health, Inc. (CANO) in Q4 2021, closing a stake of 309 shares — an estimated $391K sold.

Arrowstreet Capital first reported a position in CANO in Q1 2021 and held it in 3 quarters. The position peaked at $2.44M in Q2 2021. 131 funds tracked by Wall St. Rank hold CANO as of Q4 2021.

  • Arrowstreet Capital reported no remaining Cano Health, Inc. position as of Q4 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 309 Cano Health, Inc. shares in Q4 2021, an estimated $391K.
  • Arrowstreet Capital first reported a position in Cano Health, Inc. in Q1 2021 and held it in 3 quarters.
  • Arrowstreet Capital's Cano Health, Inc. position peaked at $2.44M in Q2 2021.
  • 131 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2021.

Based on Arrowstreet Capital's 13F filing for Q4 2021, filed 14 Feb 2022.